While targeted protein and RNA degradation are hot areas for R&D, the drugs developed so far come with limitations. Now, a new class with broader applications may not be far off. In a study published ...

In a recent study posted to the medRxiv* pre-print server, researchers extensively investigated the dynamics of antibodies induced by natural severe acute respiratory syndrome coronavirus 2 ...

Osaka, Japan – Just as a recipe contains the instructions needed to make a dish, messenger ribonucleic acid (mRNA) sequences in the body contain the information needed to make proteins. Changes in the ...

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine Canning Thoracic Institute, published in the Journal of Clinical ...

One booster dose of either of the COVID-19 RNA vaccines stood up quite well against moderate to severe disease during the omicron variant surge, the University of Oklahoma’s chief COVID officer said a ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

Arbutus Biopharma has become the latest biotech to exit the COVID-19 space as well as discontinuing its work on RNA destabilizers, tightening its focus on hepatitis B. The company’s pipeline had ...

MINNEAPOLIS -- According to the Metropolitan Council, the amount of COVID-19 RNA found in the metro's wastewater is decreasing. This is in contrast to last week, which saw a 36% increase in the amount ...

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...